FDA
-
-
-
-
-
-
-
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
-
-
-
-
-
-
-
Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results
-
-
-
-
-
-
-
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
-
-
-
-
-
-
-
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
-
-
-
-
-
-
-
Protalix BioTherapeutics Reports First Quarter 2023 Financial and Business Results
-
-
-
-
-
-
-
Protalix BioTherapeutics to Delist its Common Stock from the Tel Aviv Stock Exchange
-
-
-
-
-
-
-
Protalix BioTherapeutics to Announce Second Quarter 2022 Financial and Business Results Conference Call on August 15, 2022
-
322,220 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

